Protein intake and the use of levodopa in patients with Parkinson’s disease
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/108757 |
Resumo: | Levodopa is the principal pharmacological treatment for Parkinson’s disease (PD); however the protein content in diet may compromise its effectiveness. The aim of this study was to investigate the relationship of protein intake and the use of levodopa in ambulatory patients with PD. Thirty four PD patients were assessed for protein intake, evaluating the relation energyprotein intake by means of a register. An intake of 1762 kcal/day, 70.9 g of protein/day equivalent to 16.6% of the total energy intake as protein at a level of 1.1 g/kg bw/day. Of all patients, 47.1% took their medications with meals. We conclude that the studied patients consume more protein in their diet than those recommended for PD, with half the sample taking the medications with meals, which may affect the treatment. |
id |
UFRGS-2_7d7ac605e522c41b1380b8d3e550852f |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/108757 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Fracasso, Bianca de MoraesMorais, Maite BarcelosGomez, RosaneHilbig, ArleteRabito, Estela Iraci2015-01-06T02:14:40Z20130716-1549http://hdl.handle.net/10183/108757000909750Levodopa is the principal pharmacological treatment for Parkinson’s disease (PD); however the protein content in diet may compromise its effectiveness. The aim of this study was to investigate the relationship of protein intake and the use of levodopa in ambulatory patients with PD. Thirty four PD patients were assessed for protein intake, evaluating the relation energyprotein intake by means of a register. An intake of 1762 kcal/day, 70.9 g of protein/day equivalent to 16.6% of the total energy intake as protein at a level of 1.1 g/kg bw/day. Of all patients, 47.1% took their medications with meals. We conclude that the studied patients consume more protein in their diet than those recommended for PD, with half the sample taking the medications with meals, which may affect the treatment.La levodopa es el principal tratamiento farmacológico para la enfermedad de Parkinson, sin embargo, la proteína de la dieta puede comprometer su eficacia. El objetivo de este estudio fue investigar la ingesta de proteínas y el uso de la levodopa en pacientes con enfermedad de Parkinson tratados en régimen ambulatorio, 34 pacientes fueron evaluados. Evaluación de la ingesta de alimentos por los registros, tomas de 1762 kcal/día, 70.9 g/día, el 16,6% del total de energía y 1.1 g/kg/dia de energía y proteína, respectivamente, y que la ingesta de proteínas durante el día era 70,4% del total de proteínas diario. Todos los pacientes estaban tomando levodopa y 47,1% consumían sus medicamentos con las comidas. Se concluyó que, según las recomendaciones para la enfermedad de Parkinson, los pacientes estudiados consumían una dieta rica en proteínas y con una mayor concentración de este nutriente durante el día. Aproximadamente la mitad de la muestra ingiere los medicamentos con la comida, costumbre que puede afectar el tratamiento farmacológico de la enfermedad.application/pdfengRevista chilena de nutrición. Santiago, Chile. Vol. 40, n. 2 (Jun. 2013), p. 102-106LevodopaDoença de ParkinsonProteínasNeurodegenerative diseasesHigh protein dietDrugfood interactionsEnfermedades neurodegenerativasDieta hiperproteicaInteracciones fármaco-alimentoCarbidopaProtein intake and the use of levodopa in patients with Parkinson’s diseaseIngesta de proteínas y el uso de la levodopa en pacientes con enfermedad de Parkinson Estrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSORIGINAL000909750.pdf000909750.pdfTexto completo (inglês)application/pdf226251http://www.lume.ufrgs.br/bitstream/10183/108757/1/000909750.pdf6993356424625fcd7704ac3d0024979dMD51TEXT000909750.pdf.txt000909750.pdf.txtExtracted Texttext/plain22890http://www.lume.ufrgs.br/bitstream/10183/108757/2/000909750.pdf.txtc88cf7fe5cb775cf260562c84d4fc1b1MD52THUMBNAIL000909750.pdf.jpg000909750.pdf.jpgGenerated Thumbnailimage/jpeg1850http://www.lume.ufrgs.br/bitstream/10183/108757/3/000909750.pdf.jpg6f07ff73e9aa710949ba7e1f49ffe077MD5310183/1087572019-01-11 04:09:44.48837oai:www.lume.ufrgs.br:10183/108757Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2019-01-11T06:09:44Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
Protein intake and the use of levodopa in patients with Parkinson’s disease |
dc.title.alternative.es.fl_str_mv |
Ingesta de proteínas y el uso de la levodopa en pacientes con enfermedad de Parkinson |
title |
Protein intake and the use of levodopa in patients with Parkinson’s disease |
spellingShingle |
Protein intake and the use of levodopa in patients with Parkinson’s disease Fracasso, Bianca de Moraes Levodopa Doença de Parkinson Proteínas Neurodegenerative diseases High protein diet Drugfood interactions Enfermedades neurodegenerativas Dieta hiperproteica Interacciones fármaco-alimento Carbidopa |
title_short |
Protein intake and the use of levodopa in patients with Parkinson’s disease |
title_full |
Protein intake and the use of levodopa in patients with Parkinson’s disease |
title_fullStr |
Protein intake and the use of levodopa in patients with Parkinson’s disease |
title_full_unstemmed |
Protein intake and the use of levodopa in patients with Parkinson’s disease |
title_sort |
Protein intake and the use of levodopa in patients with Parkinson’s disease |
author |
Fracasso, Bianca de Moraes |
author_facet |
Fracasso, Bianca de Moraes Morais, Maite Barcelos Gomez, Rosane Hilbig, Arlete Rabito, Estela Iraci |
author_role |
author |
author2 |
Morais, Maite Barcelos Gomez, Rosane Hilbig, Arlete Rabito, Estela Iraci |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Fracasso, Bianca de Moraes Morais, Maite Barcelos Gomez, Rosane Hilbig, Arlete Rabito, Estela Iraci |
dc.subject.por.fl_str_mv |
Levodopa Doença de Parkinson Proteínas |
topic |
Levodopa Doença de Parkinson Proteínas Neurodegenerative diseases High protein diet Drugfood interactions Enfermedades neurodegenerativas Dieta hiperproteica Interacciones fármaco-alimento Carbidopa |
dc.subject.eng.fl_str_mv |
Neurodegenerative diseases High protein diet Drugfood interactions |
dc.subject.spa.fl_str_mv |
Enfermedades neurodegenerativas Dieta hiperproteica Interacciones fármaco-alimento Carbidopa |
description |
Levodopa is the principal pharmacological treatment for Parkinson’s disease (PD); however the protein content in diet may compromise its effectiveness. The aim of this study was to investigate the relationship of protein intake and the use of levodopa in ambulatory patients with PD. Thirty four PD patients were assessed for protein intake, evaluating the relation energyprotein intake by means of a register. An intake of 1762 kcal/day, 70.9 g of protein/day equivalent to 16.6% of the total energy intake as protein at a level of 1.1 g/kg bw/day. Of all patients, 47.1% took their medications with meals. We conclude that the studied patients consume more protein in their diet than those recommended for PD, with half the sample taking the medications with meals, which may affect the treatment. |
publishDate |
2013 |
dc.date.issued.fl_str_mv |
2013 |
dc.date.accessioned.fl_str_mv |
2015-01-06T02:14:40Z |
dc.type.driver.fl_str_mv |
Estrangeiro info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/108757 |
dc.identifier.issn.pt_BR.fl_str_mv |
0716-1549 |
dc.identifier.nrb.pt_BR.fl_str_mv |
000909750 |
identifier_str_mv |
0716-1549 000909750 |
url |
http://hdl.handle.net/10183/108757 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Revista chilena de nutrición. Santiago, Chile. Vol. 40, n. 2 (Jun. 2013), p. 102-106 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/108757/1/000909750.pdf http://www.lume.ufrgs.br/bitstream/10183/108757/2/000909750.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/108757/3/000909750.pdf.jpg |
bitstream.checksum.fl_str_mv |
6993356424625fcd7704ac3d0024979d c88cf7fe5cb775cf260562c84d4fc1b1 6f07ff73e9aa710949ba7e1f49ffe077 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
|
_version_ |
1801224861568204800 |